156 related articles for article (PubMed ID: 23188837)
1. Are increased Foxp3+ regulatory T cells responsible for immunosuppression during HTLV-1 infection? Case reports and review of the literature.
Barros N; Woll F; Watanabe L; Montes M
BMJ Case Rep; 2012 Nov; 2012():. PubMed ID: 23188837
[TBL] [Abstract][Full Text] [Related]
2. Regulatory T cell expansion in HTLV-1 and strongyloidiasis co-infection is associated with reduced IL-5 responses to Strongyloides stercoralis antigen.
Montes M; Sanchez C; Verdonck K; Lake JE; Gonzalez E; Lopez G; Terashima A; Nolan T; Lewis DE; Gotuzzo E; White AC
PLoS Negl Trop Dis; 2009 Jun; 3(6):e456. PubMed ID: 19513105
[TBL] [Abstract][Full Text] [Related]
3. FoxP3+ regulatory T cells are distinct from leukemia cells in HTLV-1-associated adult T-cell leukemia.
Toulza F; Nosaka K; Takiguchi M; Pagliuca T; Mitsuya H; Tanaka Y; Taylor GP; Bangham CR
Int J Cancer; 2009 Nov; 125(10):2375-82. PubMed ID: 19544530
[TBL] [Abstract][Full Text] [Related]
4. Human T-lymphotropic virus type 1-induced CC chemokine ligand 22 maintains a high frequency of functional FoxP3+ regulatory T cells.
Toulza F; Nosaka K; Tanaka Y; Schioppa T; Balkwill F; Taylor GP; Bangham CR
J Immunol; 2010 Jul; 185(1):183-9. PubMed ID: 20525891
[TBL] [Abstract][Full Text] [Related]
5. [Duodenal Linphoma asociated to Strongyloides stercoralis infection. Two types of HTLV-1 infection].
Guevara Miranda J; Guzmán Rojas P; Espinoza-Ríos J; Mejía Cordero F
Rev Gastroenterol Peru; 2017; 37(2):169-172. PubMed ID: 28731999
[TBL] [Abstract][Full Text] [Related]
6. Adult T cell leukemia/lymphoma: FoxP3(+) cells and the cell-mediated immune response to HTLV-1.
Bangham CR; Toulza F
Adv Cancer Res; 2011; 111():163-82. PubMed ID: 21704832
[TBL] [Abstract][Full Text] [Related]
7. Treatment of strongyloidiasis in HTLV-1 and Strongyloides stercoralis coinfected patients is associated with increased TNFα and decreased soluble IL2 receptor levels.
Salles F; Bacellar A; Amorim M; Orge G; Sundberg M; Lima M; Santos S; Porto A; Carvalho E
Trans R Soc Trop Med Hyg; 2013 Aug; 107(8):526-9. PubMed ID: 23843560
[TBL] [Abstract][Full Text] [Related]
8. Fatal outcome in a patient under immunosuppressant therapy infected with human T-lymphotropic virus type 1 (HTLV-1), cytomegalovirus (CMV) and Strongyloides stercoralis: a case report.
Ashida C; Kinoshita K; Nozaki Y; Funauchi M
BMC Infect Dis; 2020 Jul; 20(1):470. PubMed ID: 32615937
[TBL] [Abstract][Full Text] [Related]
9. HTLV-1-associated infective dermatitis demonstrates low frequency of FOXP3-positive T-regulatory lymphocytes.
Torres-Cabala CA; Curry JL; Li Ning Tapia EM; Ramos C; Tetzlaff MT; Prieto VG; Miranda RN; Bravo F
J Dermatol Sci; 2015 Mar; 77(3):150-5. PubMed ID: 25676425
[TBL] [Abstract][Full Text] [Related]
10. Predictive markers for development of strongyloidiasis in patients infected with both Strongyloides stercoralis and HTLV-1.
Satoh M; Kiyuna S; Shiroma Y; Toma H; Kokaze A; Sato Y
Clin Exp Immunol; 2003 Sep; 133(3):391-6. PubMed ID: 12930366
[TBL] [Abstract][Full Text] [Related]
11. Regulatory T cells and IgE expression in duodenal mucosa of Strongyloides stercoralis and human T lymphotropic virus type 1 co-infected patients.
Malpica L; White AC; Leguia C; Freundt N; Barros N; Chian C; Antunez EA; Montes M
PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007415. PubMed ID: 31170141
[TBL] [Abstract][Full Text] [Related]
12. Strongyloides stercoralis hyperinfection in a carrier of HTLV-I virus with evidence of selective immunosuppression.
Newton RC; Limpuangthip P; Greenberg S; Gam A; Neva FA
Am J Med; 1992 Feb; 92(2):202-8. PubMed ID: 1543206
[TBL] [Abstract][Full Text] [Related]
13. Involvement of IL-2/IL-2R system activation by parasite antigen in polyclonal expansion of CD4(+)25(+) HTLV-1-infected T-cells in human carriers of both HTLV-1 and S. stercoralis.
Satoh M; Toma H; Sugahara K; Etoh K; Shiroma Y; Kiyuna S; Takara M; Matsuoka M; Yamaguchi K; Nakada K; Fujita K; Kojima S; Hori E; Tanaka Y; Kamihira S; Sato Y; Watanabe T
Oncogene; 2002 Apr; 21(16):2466-75. PubMed ID: 11971181
[TBL] [Abstract][Full Text] [Related]
14. [Combined infection with HTLV-1 and Strongyloides stercoralis].
Pays JF
Bull Soc Pathol Exot; 2011 Aug; 104(3):188-99. PubMed ID: 21800110
[TBL] [Abstract][Full Text] [Related]
15. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis.
Carvalho EM; Da Fonseca Porto A
Parasite Immunol; 2004; 26(11-12):487-97. PubMed ID: 15771684
[TBL] [Abstract][Full Text] [Related]
16. [Fatal outcome of Strongyloides stercoralis infection in a patient with no previously known immunosuppression].
Sørensen M; Andersen O; Friis-Møller A; Kvinesdal BB
Ugeskr Laeger; 2000 May; 162(20):2894-5. PubMed ID: 10860431
[TBL] [Abstract][Full Text] [Related]
17. Early Effects of HTLV-1 Infection on the Activation, Exhaustion, and Differentiation of T-Cells in Humanized NSG Mice.
Espíndola OM; Siteur-van Rijnstra E; Frankin E; Weijer K; van der Velden YU; Berkhout B; Blom B; Villaudy J
Cells; 2021 Sep; 10(10):. PubMed ID: 34685494
[TBL] [Abstract][Full Text] [Related]
18. Human T-cell lymphotropic virus-I in Latin America.
Gotuzzo E; Arango C; de Queiroz-Campos A; Istúriz RE
Infect Dis Clin North Am; 2000 Mar; 14(1):211-39, x-xi. PubMed ID: 10738680
[TBL] [Abstract][Full Text] [Related]
19. Molecular Pathology of Adult T-Cell Leukemia/Lymphoma.
Ohshima K
Oncology; 2015; 89 Suppl 1():7-15. PubMed ID: 26550829
[TBL] [Abstract][Full Text] [Related]
20. Case Report:
De Souza JN; Soares BNRR; Goes LL; Lima CS; Barreto NMPV; Jacobina BS; Gonçalves N; Teixeira MCA; Galvão-Castro B; Grassi MFR; Soares NM
Am J Trop Med Hyg; 2018 Dec; 99(6):1583-1586. PubMed ID: 30277207
[No Abstract] [Full Text] [Related]
[Next] [New Search]
